Biochemistry, Genetics and Molecular Biology
T Cell
100%
Bevacizumab
63%
Nested Gene
54%
Peptide
50%
Mass Cytometry
36%
CD34
36%
Sample
36%
Protein
33%
Survival
31%
Electric Potential
29%
Molecule
29%
Protein Expression
27%
Data Base
26%
B Cell
23%
Polymerase Chain Reaction
23%
RNA Sequence
22%
Tumor Antigen
22%
Data Analysis
22%
Bioinformatics
20%
Flow Cytometry
20%
Gene Expression
18%
Microarray
18%
Single-Cell Protein
18%
Oncogene
18%
Chimeric Antigen Receptor
18%
Classification
18%
Antibody
18%
Tryptophan
18%
Uracil
18%
Flavivirus
18%
Merkel Cell
18%
Infectious Agent
17%
Peptide Sequence
16%
DNA
16%
Arginine
16%
Overall Survival
15%
Subtyping
15%
Time
15%
Isoform
14%
Proteomics
13%
Sequence Alignment
13%
ATF4
13%
Exercise
12%
Relapse
12%
Clinical Trial
12%
Aptitude
12%
Probe
12%
Bioassay
12%
Learning
12%
Biological Database
12%
Medicine and Dentistry
Patient
81%
Neoplasm
69%
Bevacizumab
51%
Cells
48%
T Cell
47%
Glioblastoma
47%
Gene
45%
Analysis
38%
Vaccine
38%
Combination Therapy
31%
Peptide
30%
Epitope
28%
Diseases
24%
Macrophage
22%
Mass Cytometry
21%
Therapeutic Procedure
20%
Gene Expression
20%
Phenotype
19%
Sentinel Node
18%
Flavivirus
18%
Tumor Infiltrating Lymphocyte
18%
Programmed Death-Ligand 1
18%
Tumor Recurrence
18%
Gut Microbiota
18%
Tissues
17%
Biological Marker
17%
B Cell
17%
Ovarian Cancer
16%
Inpatient
16%
Arginine
16%
In Vitro
14%
Polycythemia vera
14%
Survival
13%
Immunotherapy
12%
Immune Disorder
12%
Cytotoxic T-Cell
12%
Clear Cell Renal Cell Carcinoma
12%
Flow Cytometry
11%
T-Cell Response
11%
Protein
10%
Association
10%
Cell Therapy
10%
Observation
10%
Malignant Neoplasm
10%
Pathogen
9%
Antigen
9%
Argininosuccinate Synthase
9%
Human Leukocyte Antigen
9%
Breast Cancer
9%
Sentinel Lymph Node Biopsy
9%
Immunology and Microbiology
Cells
81%
Vaccine Efficacy
45%
Neoantigen
38%
Electric Potential
36%
Cytotoxic T-Cell
35%
Immunity
34%
T Cell Receptor
28%
Mutation
25%
Time
18%
Merkel Cell
18%
CCL22
18%
Serotype
18%
Salmonella
18%
Tumor-Infiltrating Lymphocytes
18%
Bevacizumab
18%
Gene
17%
Cancer Immunotherapy
16%
Immunotherapy
16%
Bioinformatics
15%
Infectious Agent
15%
Tumor Antigen
14%
Antigen
13%
Immune Response
13%
Carcinoma Cell
12%
Data Analysis
12%
Influenza
12%
Human Immunodeficiency Virus
12%
Polymerase Chain Reaction
11%
Phenotype
11%
Merkel Cell Polyomavirus
11%
Sample
10%
Flow
10%
Tumor Cell
10%
Biological Product
9%
Next Generation Sequencing
9%
Site Directed Mutagenesis
9%
Processing
9%
Gene Expression
9%
Human Leukocyte Antigen
9%
Tissues
9%
Strength
9%
Argininosuccinate Synthetase 1
9%
Data Base
8%
T Lymphocyte Antigen
8%
Experiment
8%
Peptide Vaccine
7%
Protein Expression
7%
Cell Line
7%
Antigen Presentation
7%
Molecule
6%
